Mylan Drops Appeal In Generic Paxil Contract Fight

Law360, New York (November 2, 2010, 5:11 PM EDT) -- Mylan Inc. has dropped its nascent appeal of a judge's refusal to enjoin Apotex Corp. from making a copycat version of Paxil CR and entered a discovery plan to litigate its claim that a previous agreement with GlaxoSmithKline PLC gives it the exclusive right to sell a generic form of the antidepressant.

Mylan told the U.S. District Court for the District of New Jersey in a letter dated Monday that all parties had agreed to scotch the appeal and asked Magistrate Judge Lois H. Goodman to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.